古鰲科技(300551.SZ)擬收購翔晟信息控股權8月20日起停牌
格隆匯8月19日丨古鰲科技(300551.SZ)公佈,公司正籌劃發行股份購買江蘇翔晟信息技術股份有限公司(“翔晟信息”)控股權。同時,上市公司擬向不超過5名特定投資者募集配套資金。此次交易構成《上市公司重大資產重組管理辦法》規定的重大資產重組。公司股票自8月20日開市起停牌,預計停牌不超10個交易日。
翔晟信息註冊資本為3800萬元,經營範圍包括計算機軟硬件開發、銷售及技術服務;網絡系統集成及技術服務;通訊產品、電子產品銷售及技術服務;網絡設備的研發、銷售;網絡信息諮詢服務;從事互聯網文化活動;文化藝術交流。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.